PAPeter J. Arnold

Peter J. Arnold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter J. Arnold has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Bladder Clot Morcellation: A Method for Expedited and Safe Removal

    by Peter J. Arnold, J. Ethan Brinkman, T. Maxwell Shelton, Marcelino E. Rivera

  • Assessing the risk of voiding dysfunction in children with ureteroceles: A systematic review and meta-analysis

    by Jin Kyu Kim, Nikhil Batra, Pete Arnold, Renee Shavnore, Konrad M. Szymanski, Martin Kaefer, Joshua Roth, Benjamin Whittam, Pankaj Dangle, Kirstan Meldrum, et al.


  • Addressing inequities in cryptorchidism care: The impact of social determinants on timely & true undescended testis referrals – A six-year study from a high-volume referral center

    by Jin Kyu Kim, Renee Shavnore, Pete Arnold, Nikhil V. Batra, Konrad M. Szymanski, Benjamin M. Whittam, Martin Kaefer, Mark P. Cain, Pankaj Dangle, Kirstan K. Meldrum, et al.


  • Open Access

    Perivascular epithelioid cell neoplasm of the bladder with peritoneal metastasis

    by Peter J. Arnold, Mabel Spio, Reem Youssef, Carina Dehner, Kevin Rice

    Perivascular epithelioid cell tumors (PEComas) are a diverse group of mesenchymal neoplasms. While they have been described throughout the genitourinary system, PEComas are quite rare within the bladder. We present the case o... | Find, read and cite all the research you need on Tech Science Press

  • Open Access

    An analysis of urodynamic parameters in diabetic and nondiabetic women

    by Ramzy T. Burns, Peter J. Arnold, Leo Song, Kevin L. Moss, Charles R. Powell

    Objectives: Diabetes is highly prevalent worldwide, with an estimated 536 million living with diabetes in 2021, and that number projected to increase to 783 million by 2045. Diabetic bladder dysfunction is thought to affect up to 60%–90% of individuals with diabetes and can significantly impact quality of life. Despite the prevalence of diabetic bladder dysfunction, the exact pathophysiological mechanism, and resulting clinical presentation, remains debated. Our objective was to compare urodynamic parameters between diabetic and nondiabetic women, assessing the impact of various markers of diabetes severity on bladder function.Methods: A retrospective chart review was conducted on female patients aged 18 and above who underwent urodynamic studies at a single tertiary care university hospital system from 2014 to 2020. Patients were categorized based on diabetes status, and diabetes severity including duration of disease, hemoglobin A1c levels, insulin dependence, and markers of end‐organ dysfunction. Urodynamic variables, including compliance, bladder voided efficiency, bladder contractility index, postvoid residual, maximum flow rate, capacity, voided volume, and detrusor overactivity, were assessed by two independent reviewers. Statistical analyses were performed to assess the impact of diabetes and diabetic severity on urodynamic parameters.Results: A total of 652 female patients were included in the study, of which, 152 (23.3%) had diabetes, with an average duration of diagnosis of 82.3 months. Diabetic women were older and had higher body mass index compared to nondiabetic women. Diabetic retinopathy and neuropathy were present in 18% and 54.6% of diabetic patients, respectively. Significant differences in urodynamic parameters were observed between diabetic and nondiabetic women, with diabetic women showing higher rates of detrusor overactivity (p = 0.01), particularly associated with increasing BMI (p = 0.03). However, classic markers of diabetes severity including duration, as well as markers of end‐organ damage, showed mixed associations with urodynamic changes.Conclusions: Despite the prevalence of diabetic bladder dysfunction and its impact on patient quality of life, the exact mechanisms and clinical presentation remain elusive. Our study highlights the significant differences in urodynamic parameters between diabetic and nondiabetic women, emphasizing the need for further research into the relationship between diabetes and diabetic bladder dysfunction.


  • Identification and Repair of Rectal Injury During Da Vinci Prostatectomy with Prior SpaceOAR Placement

    by Peter J. Arnold, Courtney Yong, Jason Farrow, Chandru P. Sundaram

    Clinical History: The patient is a 72-year-old man who underwent SpaceOAR hydrogel placement in preparation for brachytherapy for Gleason 4+3 prostate cancer at an outside hospital. However, interference from the pubic bone prevented brachytherapy seed placement. He was referred to our center for surgery. Physical Examination: Healthy-appearing man with large midline surgical scar from prior right partial colectomy. Diagnosis: Prostate cancer (Gleason 4+3 = 7). Intervention: An anterior approach radical prostatectomy was performed with the Intuitive Surgical da Vinci XI robot-assisted surgical system 75 days after SpaceOAR placement. No bowel preparation was performed. During the procedure, the posterior dissection planes were found to be significantly distorted because of the SpaceOAR. An injury to the rectum was identified ∼1.5 hours into the operation. General surgery was consulted intraoperatively. As there was no gross contamination of the field, the rectal injury was closed primarily in two layers without diversion with an overlying peritoneal flap. A sigmoidoscopy was then performed intraoperatively, which revealed a watertight closure. The rest of the procedure was completed without any further complications. Final pathology analysis showed pT2N0 Gleason 4+3 prostate cancer with negative margins. Follow-Up/Outcomes: The patient experienced an iatrogenic rectal injury during a robot-assisted radical prostatectomy, likely related to the tissue distortion caused by the previously placed SpaceOAR as has been previously reported in the literature. 1 , 2 The injury was repaired intraoperatively, with no further complications. The patient was discharged to home on postoperative day 5, and continues to do well as of his most recent follow-up 2 years postoperatively. The authors have no relevant or material financial interests that relate to the research described in this article and video production. Patient Consent Statement: The authors have received and archived patient consent for video recording/publication in advance of video recording of procedure. Music Copyright: Music featured in the video was obtained from www.royaltyfreemusicweb.com, and thus no copyright infringements have occurred as part of the production of this video. Runtime of video: 4 mins 49 secs

  • Postoperative Pancreatic Fistula Following Traumatic Splenectomy: A Morbid and Costly Complication

    by Peter Arnold, Jessica Belchos, Ashley Meagher, Christopher Robbins, Tasha Sparks Joplin, Damaris Ortiz, Ian Ferries, Jennifer Hartwell


  • The role of urethral ligation after AUS failure and end stage urethra

    by Peter J. Arnold, Mary E. Soyster, Ramzy T. Burns, Matthew J. Mellon

    Purpose To provide our single-center experience with an approach to refractory stress urinary incontinence (SUI) with permanent urethral ligation (PUL) and suprapubic tube (SPT) placement, in hopes of contributing to the limited body of research surrounding this surgical treatment option for patients with end-stage urethra (ESU). Methods All patients undergoing PUL with SPT placement from 01/01/2018 to 04/30/2022 were identified from an institutional database. Institutional Review Board exempt status was granted for the conduct of this study. Patients were seen postoperatively at 1 month and 1 year. If there were any concerns of incontinence, an antegrade urethrogram via the SPT was performed. Descriptive statistics were used to evaluate patients. Results Seven patients underwent PUL with SPT in our timeframe and were included in the study. All patients previously had an AUS placed, and two patients had a urethral sling previously placed. The median follow-up time was 21 months, ranging between 2 and 48 months. Complications included bladder spasms (43%) and continued leakage per urethra (14%). Of the 7 patients, 6 have reported continence through their urethra at their most recent follow-up. Conclusion This initial data suggest that PUL with SPT placement may be a viable surgical approach to treating refractory SUI, especially for patients with ESU who wish to avoid the morbidity associated with more formal supravesical diversion. Further study of this technique and longer follow-up is required to determine its long-term efficacy and tolerability for patients.


  • Compassion Fatigue: a Medical Student Experience

    by Peter J. Arnold, Daniel J. Romary